Development Process

2017.02

First national"perinatal stem cell industrial laboratory" was certificated and published.

2016.12

Acquisition by onetime,grasped absoulte control of Tianjin Amcellgene.

2016.06

H&B was in the list of innovation on NEW OTC Market.

2016.05

The international medical tourism pioneering zone invested by H&B in Shangrao is under construction.

H&B Life Science and Technology Museum opened offically.

2015.12

Sucessfully listed on NEW OTC Market.

2015.10

IMCELL® biological skincare birthes.

2015.07

Stock change has been made.H&B changed to limited company.

2014.08

The First HOME Program workstation is founded.

2014.04

The first academician workstation was established.

2010

Globally pioneered the technology platform of hematopoietic stem cell bank and placenta-derived pluripotent stem cell bank.

2009

Beijing stem cell bank was launched.

2007.10

H&B (Guangzhou) was incorporated, the construction of South China base was officially started.

2007.09

Obtained high-tech enterprise certification,national tax preferential policies were offered.

2007.01

H&B (Beijing) Headquarter was founded.